Ambalal Sarabhai’s JV receives CDSCO license to manufacture SARAGENE Dengue Test Kit

17 Sep 2021 Evaluate

CoSara Diagnostics, a Joint Venture (JV) of a subsidiary of Ambalal Sarabhai Enterprises and Co-Diagnostics, Inc, has obtained regulatory approval from Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell SARAGENE Dengue Test Kit. The tests are now available for sale.

SARAGENE Dengue Test Kit is an in vitro diagnostic test, based on Real-Time Polymerase Chain Reaction Technology. Test utilizes Co-Diagnostics' patented CoPrimers technology (Satterfield, 2014) (Poritz & Ririe, 2014). It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.

Ambalal Sarabhai Ent Share Price

39.36 -0.23 (-0.58%)
23-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.90
Dr. Reddys Lab 1185.95
Cipla 1533.55
Lupin 2088.85
Zydus Lifesciences 868.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...